InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

Q: How can investors listen to InspireMD's NSPR presentation at the H.C. Wainwright conference?

Investors can access a live audio webcast of InspireMD’s presentation, as well as an archived recording, through the investors page on the company’s corporate website at https://investors.inspiremd.com.

Q: Will a replay of InspireMD's NSPR H.C. Wainwright conference presentation be available?

Yes. An archive of the recording of InspireMD’s H.C. Wainwright conference presentation will be available on the investors page of the company’s website after the live event.

InspireMD (NSPR) will present at the H.C.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

InspireMD (NSPR) will present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14 at 2:30 p.m. Eastern Time.

A live audio webcast and archived replay will be accessible via the investors page on the company’s website. Investors can contact their institutional representative to request a meeting or obtain additional conference details.

Market Context

NSPR’s prior close was $0.8402 before the announcement. The scheduled presentation provided an inves...

Analysis

NSPR’s prior close was $0.8402 before the announcement. The scheduled presentation provided an investor-access event but no operating outcome; the active, non-effective S-3 shelf dated Aug 6, 2025 remained a financing consideration.

Key Figures

Conference date: September 14th Presentation time: 2:30 pm Eastern Time Conference edition: 28th annual

3 metrics

Conference date September 14th Upcoming H.C. Wainwright conference

Presentation time 2:30 pm Eastern Time September 14th presentation

Conference edition 28th annual H.C. Wainwright Global Investment Conference

Historical Context

5 past events · Latest: Aug 17 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 17	Second-quarter earnings	Negative	-10.4%	Recall impacts and widened net loss accompanied second-quarter results.
Aug 10	Earnings-date notice	Neutral	+3.8%	Company scheduled its second-quarter results release and investor conference call.
Aug 07	Inducement share grants	Negative	+8.0%	Company approved restricted-stock inducement grants totaling 221,666 shares.
Jul 30	Leadership appointment	Positive	-3.3%	Kathleen Kennedy joined as senior vice president of global sales and marketing.
Jun 12	Inducement share grants	Negative	+4.1%	Company approved inducement grants covering 91,161 restricted shares.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The latest earnings report aligned with a negative reaction, while recent inducement-grant announcements rose despite their dilutive characterization.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

09/03/2026 - 08:00 AM

MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28^th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).

A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors.inspiremd.com.

To request a meeting or for more details about the conferences, please reach out to your institutional contact.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com

FAQ

When will InspireMD (NSPR) present at the H.C. Wainwright 28th Annual Global Investment Conference?

InspireMD is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14 at 2:30 p.m. Eastern Time (ET).

How can investors listen to InspireMD's NSPR presentation at the H.C. Wainwright conference?

Investors can access a live audio webcast of InspireMD’s presentation, as well as an archived recording, through the investors page on the company’s corporate website at https://investors.inspiremd.com.

Will a replay of InspireMD's NSPR H.C. Wainwright conference presentation be available?

Yes. An archive of the recording of InspireMD’s H.C. Wainwright conference presentation will be available on the investors page of the company’s website after the live event.

How can investors request a meeting with InspireMD (NSPR) at the H.C. Wainwright conference?

To request a meeting with InspireMD or obtain more details about the H.C. Wainwright conference, investors are asked to reach out to their institutional contact.